Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
19.80
+0.20 (1.02%)
At close: Oct 9, 2024

Silco Pharmaceuticals Company Description

Silco Pharmaceuticals Limited manufactures and markets finished pharmaceutical products in Bangladesh.

The company offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxatives, lipid lowering agents, mycolytic expectorants, and NSAIDs, as well as multi-medicines.

It provides its products in various human drugs dosage forms, such as tablets, capsules, syrups, oral solids and liquids, suspension and powder for suspension, etc. The company also exports its medicines to Afghanistan, Bhutan, Myanmar, Ivory Coast, Kenya, Mauritius, Somalia, Tanzania, Uganda, and internationally.

Silco Pharmaceuticals Limited was incorporated in 1995 and is headquartered in Sylhet, Bangladesh.

Silco Pharmaceuticals Limited
Country Bangladesh
Founded 1995
Industry Pharmaceutical Preparations
Employees 311
CEO Md. Haque Rukan

Contact Details

Address:
41, Nurani
Sylhet, 3100
Bangladesh
Phone 880 821 722 241
Website silcopharma.com

Stock Details

Ticker Symbol SILCOPHL
Exchange Dhaka Stock Exchange
Fiscal Year July - June
Reporting Currency BDT
SIC Code 2834

Key Executives

Name Position
Md. Haque Rukan Chief Executive Officer
Md. Alam Chief Financial Officer